Navigation Links
Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
Date:5/15/2013

NASHVILLE, Tenn., May 15, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the UBS Global Healthcare Conference at the Sheraton New York hotel on Monday, May 20, 2013, at 9:30 a.m. Eastern Time.

The presentation will be simultaneously webcast and can be accessed through the Investor Relations section of Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.

Shortly following the live webcast a replay will also be available on the Company's website.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® for the treatment of acetaminophen poisoning, Caldolor®, the first injectable treatment for pain and fever approved in the United States, and Kristalose®, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information, please visit the Company website at www.cumberlandpharma.com.

 


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter Financial Results
2. Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
3. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
4. Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013
5. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
6. Cumberland Emerging Technologies Expands Life Sciences Center
7. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
8. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
9. Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
10. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
11. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2019)... (PRWEB) , ... August 16, 2019 , ... ... aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the ... are around 150 million people worldwide that are affected by treatment-resistant hypertension, resulting ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... since 2005, announced it has successfully completed enrollment of 690 patients for a ... a dose ranging, multicenter, randomized, double-blind, placebo-controlled, home use, parallel group clinical trial ...
(Date:8/14/2019)... ... August 14, 2019 , ... Bach Pharma, Inc., a ... its drug platform GVT (Monosodium Luminol), created to treat and cure multiple neurodegenerative ... data from multiple animal studies have proven that GVT has the potential to ...
Breaking Medicine Technology:
(Date:8/14/2019)... , ... August 14, 2019 , ... Teguar Corporation has ... in America. This list has long-been established as a mark of success for some ... Dell, and Oracle. Teguar made the list in 2015, 2016 and 2017. This year, ...
(Date:8/14/2019)... ... August 14, 2019 , ... ... Team Assistant support, has earned a place on the Inc. magazine 500/5000 list ... inclusion marks nearly a decade of ScribeAmerica’s recognition as one of the fastest ...
(Date:8/14/2019)... ... August 13, 2019 , ... New Hampshire-based Vera Roasting Company , makers ... expansion of its line of CBD-infused coffees with the release of a new higher-dosage ... bag. , “We are excited to expand our CBD-infused product lines to include ...
(Date:8/14/2019)... (PRWEB) , ... August 13, 2019 , ... In a ... the purpose of doubt in your belief systems. , “Doubt can obliterate your old ... on the path to examining them to expand your understanding and your awareness. Trust ...
(Date:8/14/2019)... ... August 14, 2019 , ... While it is commonly ... their food and beverage choices can help them manage and, in some cases, reverse ... finds that about a quarter of U.S. adults are trying to manage a health ...
Breaking Medicine News(10 mins):